McKesson Corporation
NYSE:MCKMedical - Distribution
-$28.96 today
- Market cap
- $125.21B
- Beta
- 0.32
- P/E (TTM)
- 19.3
- EPS (TTM)
- $39.00
- Dividend yield
- 0.44%
Volume 0.67M
Average 1.03M
MCK Deferred Revenue (Non-current)
Payments received for goods or services the company will deliver after more than one year.
McKesson CorporationNYSE: MCK
Deferred Revenue (Non-current) · Q1 FY2027 · quarter ended Jun 2026
Deferred revenue (non-current) remains negative
Q1 FY2027 deferred revenue (non-current) was $0, compared with $0 a year earlier.
Context
- Deferred revenue (non-current) amounted to 0.0% of total assets at the end of Q1 FY2027, unchanged from a year earlier.
- Deferred revenue (non-current) increased in 0 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue (Non-current) history
USD · from the balance sheet
- Latest · FY2026
- 0 USD
- Year-over-year change
- —
| Period | Period end | Deferred Revenue (Non-current) | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 0 | — |
| FY2025 | 2025-03-31 | 0 | — |
| FY2024 | 2024-03-31 | 0 | — |
| FY2023 | 2023-03-31 | 0 | — |
| FY2022 | 2022-03-31 | 0 | — |
Deferred Revenue (Non-current) vs competitors
How MCK compares with its peers on the latest reported figures
- MCK's Jun 2026 deferred revenue (non-current) of $0 is the highest of the 4 companies compared; the peer median is $0.
- Deferred revenue (non-current) amounts to 0.0% of total assets for MCK, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding MCK) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for MCK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3.53B | 4.68B | 4.58B | 5.69B | 3.98B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 18.58B | 19.41B | 21.62B | 25.64B | 27.99B |
| Inventory | 18.7B | 19.69B | 21.14B | 23B | 24.21B |
| Other Current Assets | 4.52B | 513M | 626M | 1.06B | 1.04B |
| Total Current Assets | 46.23B | 44.29B | 47.97B | 55.4B | 57.21B |
| Property, Plant & Equipment (Net) | 3.64B | 3.81B | 4.05B | 4.28B | 4.73B |
| Goodwill | 9.45B | 9.95B | 10.13B | 10.02B | 11.32B |
| Intangible Assets | 2.06B | 2.28B | 2.11B | 1.46B | 4.08B |
| Long-term Investments | 0 | 312M | 348M | 0 | 267M |
| Tax Assets | 0 | (312M) | 0 | 0 | 0 |
| Other Non-current Assets | 1.92B | 1.99B | 2.84B | 3.97B | 4.73B |
| Total Non-current Assets | 17.07B | 18.03B | 19.47B | 19.74B | 25.11B |
| Total Assets | 63.3B | 62.32B | 67.44B | 75.14B | 82.32B |
| Account Payables | 38.09B | 42.49B | 47.1B | 55.33B | 59.97B |
| Short-term Debt | 799M | 968M | 50M | 1.19B | 1.27B |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.74B | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 48.47B | 47.96B | 52.36B | 61.6B | 67.02B |
| Long-term Debt | 5.08B | 4.63B | 5.58B | 4.46B | 5.11B |
| Deferred Tax Liabilities | 1.42B | 1.39B | 917M | 1.03B | 1.33B |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 8.76B | 8.44B | 8.72B | 8.26B | 7.75B |
| Total Non-current Liabilities | 16.62B | 15.85B | 16.69B | 15.23B | 16.14B |
| Total Liabilities | 65.09B | 63.81B | 69.04B | 76.83B | 83.16B |
| Common Stock | 2M | 3M | 3M | 3M | 3M |
| Retained Earnings | 9.03B | 12.3B | 14.98B | 17.92B | 22.29B |
| Accumulated OCI | (1.53B) | (905M) | (881M) | (932M) | (1.45B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 708M |
| Minority Interest | 480M | 367M | 372M | 380M | 1.34B |
| Total Equity | (1.79B) | (1.49B) | (1.6B) | (1.69B) | (834M) |
| Total Debt | 7.54B | 7.3B | 7.39B | 7.39B | 8.61B |
| Net Debt | 4.01B | 2.62B | 2.81B | 1.7B | 4.64B |
McKesson Corporation
NYSE:MCK
Intrinsic Alpha fair value
Locked
Current Price
$1,084.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.